Skepticism to Standard of Care: The T-Cell Journey, ft. Dr. James Mulé
The ImmunoVerse™
00:00
FDA Approval of TIL for Advanced Melanoma
Dr. Patrick Hwu asks about the FDA approval; Mulé reflects on the approval's significance and frames it as a new beginning for expanding TIL use.
Play episode from 13:35
Transcript
